News

Trident Lifeline Ltd share price inched up 4.21% to Rs 434.5 after the company`s net profit saw a strong growth of 30.18% to Rs 6.6 crore, while revenue from operations increased sharply by 39.62% to Rs 47.08 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, rising 4.06%. It has marginally improved by 3.17% over last one week and dipped slightly by 0.26% in last one month while the market capitalization of Trident Lifeline Ltd has gained 12% and 62.17% in the same period respectively. Profit before tax (PBT) of Trident Lifeline Ltd stood at Rs 8.81 crore in Q3 FY26, rallying 32.88% year-on-year, and expanding by 33.28% quarter-on-quarter. EBITDA came in at Rs 10 crore, jumping 99.42% YoY and surging by 30.35% sequentially. Total expenses witnessed a sharp rise of 39.10% to Rs 37.32 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 7.76 crore, registering a fall of 35.28% YoY, while employee benefits expense was at Rs 3.06 crore, witnessing a strong rise of 81.07% YoY. For the TTM ended FY26, revenue from operations surged 48.37% to Rs 129.02 crore, while net profit jumped 84.18% to Rs 19.32 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 621% to Rs 18.84 crore, and PBT witnessed a strong rise of 99.78% to Rs 27.19 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 4.69 crore in FY26, as against Rs 10.24 crore in FY25. Trident Lifeline Ltd surged by 45.81% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.19% during the same period.

Trident Lifeline Limited held an Extra-ordinary General Meeting (EOGM) on Tuesday, October 27, 2026, via video conference, where shareholders approved three special resolutions: an alteration of the company’s Articles of Association, the issuance of equity shares to proposed allottees on a preferential basis, and the issuance of warrants convertible into equity shares to proposed allottees on a preferential basis. The meeting, chaired by Hardik Desai, Executive Director and Chairman, commenced at 4:00 p.m. (IST) and concluded at 4:11 p.m. (IST), with e-voting concluding 15 minutes later, and results to be submitted to the BSE Limited and posted on the company`s website within 48 working hours.

Trident Lifeline Ltd share price inched up 2.44% to Rs 416.95 after the company`s net profit saw a strong growth of 30.18% to Rs 6.6 crore, while revenue from operations increased sharply by 39.62% to Rs 47.08 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, gaining 3.38%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of Trident Lifeline Ltd has improved by 3.72% and 57.65% in the same period respectively. Profit before tax (PBT) of Trident Lifeline Ltd stood at Rs 8.81 crore in Q3 FY26, expanding by 32.88% year-on-year, and jumping 33.28% quarter-on-quarter. EBITDA came in at Rs 10 crore, surging by 99.42% YoY and rallying 30.35% sequentially. Total expenses surged 39.10% to Rs 37.32 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 7.76 crore, registering a fall of 35.28% YoY, while employee benefits expense was at Rs 3.06 crore, surging 81.07% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 48.37% to Rs 129.02 crore, while net profit jumped 84.18% to Rs 19.32 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 621% to Rs 18.84 crore, and PBT soared 99.78% to Rs 27.19 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 4.69 crore in FY26, as against Rs 10.24 crore in FY25. Trident Lifeline Ltd soared by 39.92% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 13.18% during the same period.

Trident Lifeline Limited will hold a board meeting on October 26, 2026, to consider and approve the unaudited financial results for the half year ended September 30, 2026, and to declare a first interim dividend for the financial year 2026-27, if approved. The company’s trading window for equity shares was closed from October 1, 2026, and will reopen 48 hours after the meeting’s results are made public on October 26, 2026.

Trident Lifeline Limited announced the allotment of 24,000 equity shares with a face value of Rs 10 each to Vishal Bhupendra Halwawala upon the conversion of an equal number of warrants, receiving Rs 47,88,000 in the process, according to a filing with the BSE Limited on October 17, 2026. The allotment, which follows an earlier warrant issue price of Rs 266 per warrant, increases the company`s issued, subscribed, and paid-up equity share capital to Rs 11,98,10,000, consisting of 11,98,1000 equity shares.